Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
96.00    -1.50 (-1.54%)
Bid:
94.00
Ask:
98.00
Spread: 4.00 (4.255%)
Market Cap: £111.67m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

TVR

3 Mar 2026 15:30

RNS Number : 1326V
Brave Bison Group PLC
03 March 2026
Β 

Β 

Brave Bison Group plc

Β 

("Brave Bison" or the "Company", together with its subsidiaries "the Group")Β 

Β 

Total Voting Rights

Β 

and

Β 

Update to Issue of Equity

Β 

Pursuant to the announcement dated 2 March 2026 and as a result of a clerical error, the Group will now be receiving a total of 2,905,899 ordinary shares in System1 in exchange for 9,763,821 ordinary shares in Brave Bison. The Group's resultant shareholding of 28% in in System1 remains materially unchanged.

Β 

As a result, application has been made for the revised total of 9,763,821 new ordinary shares, to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 4 March 2026 and the new ordinary shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares. The new ordinary shares in Brave Bison will represent 8.7% of the Group's enlarged issued share capital following Admission.

Β 

On Admission, the Company will have a total of 112,238,119 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 112,238,119 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Β 

For further information please contact:?Β 

?Β 

Brave Bison Group plc via CavendishΒ 

Oliver Green, Executive ChairmanΓ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Γ―ΒΏΒ½Β 

Theo Green, Chief Growth Officer?Β 

Philippa Norridge, Chief Financial Officer?Β 

?Β 

Cavendish Capital Markets Tel: +44 (0) 20 7220 0500Β 

Nominated Adviser & Joint Broker?Β 

Ben Jeynes?/ Teddy Whiley / Elysia Bough - Corporate FinanceΒ 

Michael Johnson / Sunila de Silva - ECM

Β 

Singer Capital Markets Tel: +44 (0) 20 7496 3000Β 

Joint BrokerΒ Β 

Alex Bond / Sara Hale

Β 

About Brave BisonΒ 

Β 

Brave Bison is a media, marketing and technology partner for global brands. With operations across eight countries including the UK, US, India, Australia and Egypt, Brave Bison supports customers with marketing consultancy, execution and training services via a connected, AI-enabled operating model.

Β 

The company operates through three divisions: marketing consultancy, marketing training and sport and entertainment. The marketing consultancy division designs and deploys bespoke, insight-led and AI-enabled growth strategies for global brands and businesses including New Balance, Primark and Google via specialist agencies including SocialChain and MTM. The sport and entertainment division monetises content and scales communities for the biggest creators, teams and federations on the planet-from Real Madrid to the US Open. Finally, the marketing training division, MiniMBA, is an eLearning platform offering industry-leading MBA-level training in brand, marketing and business strategy for leading global enterprises such as Carlsberg, NestlΓ© and Salesforce.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRAKNBQKBKDANK
Date   Source Headline
19th Jun 20264:26 pmRNSHolding(s) in Company
17th Jun 20264:41 pmRNSResult of Annual General Meeting
17th Jun 20267:00 amRNSAGM Statement
15th Jun 20267:00 amRNSMark Ritson Option Exercise
8th Jun 20265:17 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.